MDPI Contact

MDPI AG
St. Alban-Anlage 66,
4052 Basel, Switzerland
Support contact
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18

For more contact information, see here.

Advanced Search

You can use * to search for partial matches.

Search Results

2 articles matched your search query. Search Parameters:
Authors = Robert Doms

Matches by word:

ROBERT (1683) , DOMS (12)

View options
order results:
result details:
results per page:
Articles per page View Sort by
Displaying article 1-50 on page 1 of 1.
Export citation of selected articles as:
Open AccessReview Making Bunyaviruses Talk: Interrogation Tactics to Identify Host Factors Required for Infection
Viruses 2016, 8(5), 130; doi:10.3390/v8050130
Received: 19 March 2016 / Revised: 3 May 2016 / Accepted: 6 May 2016 / Published: 13 May 2016
Viewed by 761 | PDF Full-text (685 KB) | HTML Full-text | XML Full-text
Abstract
The identification of host cellular genes that act as either proviral or antiviral factors has been aided by the development of an increasingly large number of high-throughput screening approaches. Here, we review recent advances in which these new technologies have been used to
[...] Read more.
The identification of host cellular genes that act as either proviral or antiviral factors has been aided by the development of an increasingly large number of high-throughput screening approaches. Here, we review recent advances in which these new technologies have been used to interrogate host genes for the ability to impact bunyavirus infection, both in terms of technical advances as well as a summary of biological insights gained from these studies. Full article
(This article belongs to the Special Issue Recent Progress in Bunyavirus Research) Printed Edition available
Open AccessReview Gene Therapy Targeting HIV Entry
Viruses 2014, 6(3), 1395-1409; doi:10.3390/v6031395
Received: 4 November 2013 / Revised: 19 February 2014 / Accepted: 26 February 2014 / Published: 21 March 2014
Cited by 10 | Viewed by 2375 | PDF Full-text (565 KB) | HTML Full-text | XML Full-text
Abstract
Despite the unquestionable success of antiretroviral therapy (ART) in the treatment of HIV infection, the cost, need for daily adherence, and HIV-associated morbidities that persist despite ART all underscore the need to develop a cure for HIV. The cure achieved following an allogeneic
[...] Read more.
Despite the unquestionable success of antiretroviral therapy (ART) in the treatment of HIV infection, the cost, need for daily adherence, and HIV-associated morbidities that persist despite ART all underscore the need to develop a cure for HIV. The cure achieved following an allogeneic hematopoietic stem cell transplant (HSCT) using HIV-resistant cells, and more recently, the report of short-term but sustained, ART-free control of HIV replication following allogeneic HSCT, using HIV susceptible cells, have served to both reignite interest in HIV cure research, and suggest potential mechanisms for a cure. In this review, we highlight some of the obstacles facing HIV cure research today, and explore the roles of gene therapy targeting HIV entry, and allogeneic stem cell transplantation in the development of strategies to cure HIV infection. Full article
(This article belongs to the Special Issue Gene Therapy for Retroviral Infections)

Years

Subjects

Refine Subjects

Journals

Refine Journals

Article Types

Refine Types

Countries

Refine Countries
Back to Top